Tadayoshi Takegoshi - Concepedia

Author

Tadayoshi Takegoshi

Kanazawa University ORCID

Also Known As

T TAKEGOSHI, T Takegoshi, T. Takegoshi, TADA-YOSHI TAKEGOSHI, Tadayoshi TAKEGOSHI, Tadayoshi Takegoshi, Yoshihito Kita

Publications

1.5K

Citations

H-Index

Concepts

All Affiliations

Kanazawa University Fukui Prefectural Hospital Komatsu (Japan)Hokuriku University Uwajima City Hospital

About

Tadayoshi Takegoshi is an author at Kanazawa University specializing in medicine, atherosclerosis, and cardiovascular disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	16	913
2	Health Sciences	5	5	163
3	Public Health	5	5	586
4	Biochemistry	4	4	151
5	Clinical Nutrition	1	1	11

Tadayoshi Takegoshi

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia Hiroshi Mabuchi, Junji Koizumi, Masami Shimizu, The American Journal of Cardiology Metabolic SyndromeFamilial HypercholesterolemiaCardiovascular DiseaseLow-density Lipoprotein ApheresisHyperlipidemia	1998	291
Circulating Matrix Metalloproteinases and Their Inhibitors in Premature Coronary Atherosclerosis Yoshihiro Noji, Kouji Kajinami, Masa‐aki Kawashiri, Clinical Chemistry and Laboratory Medicine (CCLM)	2001	151
Discrimination of familial hypercholesterolemia and secondary hypercholesterolemia by achilles' tendon thickness Hiroshi Mabuchi, Satoshi Ito, Toshihiro Haba, Atherosclerosis HypertensionFamilial HypercholesterolemiaBody CompositionLipid DisorderCardiovascular Disease	1977	112
Causes of death in patients with familial hypercholesterolemia Hiroshi Mabuchi, Susumu Miyamoto, Kosei Ueda, Atherosclerosis Metabolic SyndromeFamilial HypercholesterolemiaLipid DisorderCardiovascular DiseaseGenetic Epidemiology	1986	103
Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation Hiroshi Mabuchi, Atsushi Nohara, Tohru Noguchi, Atherosclerosis Lipid DisorderHomozygous Familial HypercholesterolemiaGenetic DisorderGeneticsInherited Metabolic Disease	2014	87
Long-term treatment with pitavastatin (NK-104), a new HMG-CoA reductase inhibitor, of patients with heterozygous familial hypercholesterolemia Yoshihiro Noji, Toshinori Higashikata, Akihiro Inazu, Atherosclerosis Metabolic SyndromeHeterozygous Familial HypercholesterolemiaCardiovascular DiseaseHematologyPharmacology	2002	74
Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia Kouji Kajinami, Junji Koizumi, Kosei Ueda, The American Journal of Cardiology Metabolic SyndromeLipid DisorderOxysterolHeterozygous Familial HypercholesterolemiaBiochemistry	2000	68
Impact of Severe Earthquake on the Occurrence of Acute Coronary Syndrome and Stroke in a Rural Area of Japan Experience From the Noto Peninsula Earthquake Masayuki Tsuchida, Masa‐aki Kawashiri, Ryota Teramoto, Circulation Journal	2009	57
Achilles tendon thickness and ischemic heart disease in familial hypercholesterolemia Hiroshi Mabuchi, Ryozo Tatami, Toshihiro Haba, Metabolism Metabolic SyndromeHypertensionHeart FailureVascular DiseaseFamilial Hypercholesterolemia	1978	42
Reduction of lipoprotein(a) by LDL-apheresis using a dextran sulfate cellulose column in patients with familial hypercholesterolemia Junji Koizumi, Ichiro Koizumi, Yoshihide Uno, Atherosclerosis Metabolic SyndromeFamilial HypercholesterolemiaOxysterolCardiovascular DiseaseBiochemistry	1993	40

Page 1